Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:TSVT

2seventy bio (TSVT) Stock Price, News & Analysis

2seventy bio logo

About 2seventy bio Stock (NASDAQ:TSVT)

Advanced Chart

Key Stats

Today's Range
$5.00
$5.00
50-Day Range
$4.99
$5.00
52-Week Range
$2.29
$5.30
Volume
N/A
Average Volume
650,169 shs
Market Capitalization
$266.15 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.00
Consensus Rating
Hold

Company Overview

Receive TSVT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for 2seventy bio and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

TSVT Stock News Headlines

Warren Buffett Issues Cryptic Warning on U.S. Dollar
Imagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA or Bitcoin, but by owning a simple index fund. It sounds impossible. Yet it happened – just a short time ago. Now a legendary figure says: "Brace yourselves. It's about to happen here, in America. But fair warning – it could be the worst thing that ever happens to you." This story has received little coverage in the press. But if history repeats, it could bump tens of millions of Americans into a 7-figure net worth practically overnight.tc pixel
2seventy Bio reports Q4 EPS (37c) vs ($1.11) last year
2seventy Bio price target lowered to $5 from $6 at Morgan Stanley
See More Headlines

TSVT Stock Analysis - Frequently Asked Questions

2seventy bio, Inc. (NASDAQ:TSVT) issued its earnings results on Wednesday, May, 7th. The company reported $0.01 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.10) by $0.11. The company earned $22.94 million during the quarter, compared to analysts' expectations of $13.96 million. 2seventy bio had a negative trailing twelve-month return on equity of 53.65% and a negative net margin of 207.25%.

Based on aggregate information from My MarketBeat watchlists, some other companies that 2seventy bio investors own include Tesla (TSLA), Advanced Micro Devices (AMD), JPMorgan Chase & Co. (JPM), Netflix (NFLX), Home Depot (HD), Meta Platforms (META) and NVIDIA (NVDA).

Company Calendar

Last Earnings
5/07/2025
Today
9/04/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:TSVT
CIK
1860782
Fax
N/A
Employees
440
Year Founded
N/A

Price Target and Rating

High Price Target
$5.00
Low Price Target
$5.00
Potential Upside/Downside
0.0%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.10)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$217.57 million
Net Margins
-207.25%
Pretax Margin
-207.25%
Return on Equity
-53.65%
Return on Assets
-23.67%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
4.95
Quick Ratio
4.95

Sales & Book Value

Annual Sales
$48.37 million
Price / Sales
5.50
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$5.04 per share
Price / Book
0.99

Miscellaneous

Outstanding Shares
53,230,000
Free Float
47,874,000
Market Cap
$266.15 million
Optionable
Optionable
Beta
1.04
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (NASDAQ:TSVT) was last updated on 9/5/2025 by MarketBeat.com Staff
From Our Partners